Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,942,563 papers from all fields of science
Search
Sign In
Create Free Account
NHL-BFM-90 Regimen
Known as:
BFM-90 Regimen
A regimen used for the treatment of localized aggressive forms of childhood B-cell non-Hodgkin's lymphoma, including lymphoblastic lymphoma.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
ASPARAGINASE
Childhood Anaplastic Large Cell Lymphoma
Childhood Diffuse Large B -Cell Lymphoma
Cyclophosphamide
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
ХИМИОТЕРАПИЯ ПО ПРОГРАММЕ R-mNHL-BFM-90 В КОМБИНАЦИИ С ЛЕНАЛИДОМИДОМ КАК ТЕРАПИЯ ПЕРВОЙ ЛИНИИ У БОЛЬНЫХ MUM1-ПОЗИТИВНОЙ ДИФФУЗНОЙ В-КРУПНОКЛЕТОЧНОЙ ЛИМФОМОЙ И ФОЛЛИКУЛЯРНОЙ ЛИМФОМОЙ 3…
Н. Г. Габеева
,
Д. А. Королева
,
+13 authors
Е. Е. Звонков
2019
Corpus ID: 216574757
Introduction. Diffuse large B-cell lymphoma of postgerminal origin (ABC-DLBCL) and follicular lymphoma grade 3B (FL3B) are…
Expand
2019
2019
CHEMOTHERAPY ACCORDING TO THE R-mNHL-BFM-90 PROTOCOL IN COMBINATION WITH LENALIDOMIDE AS THE FIRST LINE THERAPY IN PATIENTS WITH MUM1-POSITIVE DIFFUSIVE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA…
N. Gabeeva
,
D. Koroleva
,
+13 authors
E. Zvonkov
Russian journal of hematology and transfusiology
2019
Corpus ID: 242352218
Introduction.Diffuse large B-cell lymphoma of postgerminal origin (ABC-DLBCL) and follicular lymphoma grade 3B (FL3B) are…
Expand
2019
2019
[Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].
Y. Li
,
Q. Yin
,
+5 authors
Y. P. Song
Zhonghua yi xue za zhi
2019
Corpus ID: 73471067
Objective: To evaluate the efficacy and safety of rituximab combined with the modified NHL-BFM-90 protocol in childhood and…
Expand
Review
2018
Review
2018
Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature.
N. Gabeeva
,
E. Zvonkov
,
D. Koroleva
,
M. Chukavina
,
T. Obukhova
,
A. Kovrigina
Терапевтический архив
2018
Corpus ID: 73411732
Diffuse large B-cell lymphoma is categorized by gene expression profiling into germinal center (GCB) and activated B-cell (ABC…
Expand
2017
2017
PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma
W. Zheng
,
H. Ren
,
+13 authors
Jun Zhu
Chinese journal of cancer research = Chung-kuo…
2017
Corpus ID: 15180374
Objective Although L-asparaginase (L-ASP) is a standard treatment for lymphoblastic lymphoma (LBL), hypersensitivity reactions by…
Expand
2014
2014
Влияние программной химиотерапии на функциональное состояние головного мозга у детей с лимфоидными опухолями (Е.И. Кузнецова)
E. I. Kuznetsova
2014
Corpus ID: 73961642
The aim of this work was assessment of the brain functional state and to find an electroencephalogramm (EEG)-predictors of…
Expand
2009
2009
[First experience of using modified program NHL-BFM-90 for the treatment of primary diffuse large-B-cell lymphosarcoma of the bones and soft tissues with poor-prognosis].
A. K. Morozova
,
E. Zvonkov
,
+10 authors
S. Kravchenko
Терапевтический архив
2009
Corpus ID: 7372773
AIM To evaluate efficacy of intensive modified program NHL-BFM-90 (mNHL-BFM-90) in adult poor-prognosis patients with diffuse…
Expand
2007
2007
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
Xiao-fei Sun
,
Zi-jun Zhen
,
+8 authors
Z. Guan
Zhonghua zhong liu za zhi [Chinese journal of…
2007
Corpus ID: 23187552
OBJECTIVE This study was designed to evaluate the efficacy and toxicity of modified BFM-90 regimen originated from Germany…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE